Pfizer (NYSE:PFE) To Divest Entire 7 Percent Stake In Haleon Through Share Offering
Pfizer (NYSE:PFE) announced its intention to sell its entire residual shareholding in Haleon plc, reflecting a divestment ...
PMLive12h
Pfizer/Arvinas’ vepdegestrant shows promise in phase 3 breast cancer study
The phase 3 VERITAC-2 trial has been evaluating the candidate against AstraZeneca’s endocrine therapy Faslodex (fulvestrant) ...
The Zacks Analyst Blog Highlights Novo Nordisk, Roche, Pfizer, Arvinas and J&J
Novo Nordisk announced disappointing data from a phase III study on a novel obesity candidate, CagriSema. Roche announced a ...
Arvinas price target lowered to $12 from $48 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Arvinas (ARVN) to $12 from $48 and keeps an Equal Weight rating on the shares after the ...
Investing2d
Arvinas’s SWOT analysis: vepdegestrant potential drives stock outlook
Arvinas has been exploring the potential of vepdegestrant in combination therapies. The company has shown promising results when combining vepdegestrant with Pfizer (NYSE:PFE)’s CDK inhibitors ...
PharmExec6d
Phase III Trial Data Show Vepdegestrant Produces Encouraging Outcomes in ER+/HER2- Advanced or Metastatic Breast Cancer
Topline results from the Phase III VERITAC-2 trial found that vepdegestrant provided a statistically significant and ...
Is Arvinas, Inc. (ARVN) a Pump and Dump Stock Favored by Hedge Funds?
We recently compiled a list of the 10 Pump and Dump Stocks Favored by Hedge Funds. In this article, we are going to take a ...